Everything you need to know about the transition nobody warned you about, and what to actually do about it.
Take the Free Hormone QuizThis guide covers everything: what perimenopause actually is, what the symptoms feel like at each stage, why it is so frequently confused with other conditions, and how a root-cause approach to treatment can meaningfully change how you experience this transition.
Perimenopause is the hormonal transition period before menopause, during which oestrogen and progesterone levels fluctuate unpredictably rather than falling in a steady line. It typically begins in the early to mid 40s, though it can start in the late 30s, and lasts anywhere from two to twelve years. Symptoms range from hot flushes and irregular cycles to brain fog, anxiety, joint pain, and disrupted sleep. In South Africa, perimenopause is widely under-recognised in primary care, and many women spend years being treated for anxiety, depression, or thyroid problems without anyone connecting their symptoms to hormonal transition.
Perimenopause means literally “around menopause.” It is the transitional phase during which the ovaries gradually reduce their output of oestrogen and progesterone, a process that is rarely smooth or linear. Menopause itself is defined as twelve consecutive months without a period. Everything before that endpoint, sometimes for many years, is perimenopause.
The average age of natural menopause in South African women is approximately 50 to 51. That means perimenopause typically begins somewhere in the early to mid 40s. But the range is wide: some women begin experiencing meaningful hormonal changes in their late 30s, and others sail through their early 40s without any significant disruption. Genetics, stress load, nutritional status, body composition, and environmental exposure all influence both when the transition begins and how severe the symptoms are.
What makes perimenopause genuinely different from other forms of hormone imbalance is the unpredictability. Unlike the relatively steady pattern of, say, oestrogen dominance in the 30s, perimenopausal hormones swing erratically. Oestrogen can surge higher than normal in some cycles, causing heavy bleeding and breast tenderness, then plummet low in others, triggering hot flushes and mood crashes. Progesterone, which declines earlier and more steeply than oestrogen, is frequently the first deficiency driving symptoms. This volatility, rather than a simple deficiency, is what makes perimenopause so difficult to diagnose from a single blood test and so varied in its presentation between women.
Cycles are still regular but may begin to shorten slightly. Progesterone declines while oestrogen remains relatively normal or may even surge. The dominant pattern at this stage is relative oestrogen dominance due to falling progesterone. Symptoms include worsening PMS, heavier periods, breast tenderness, new or increased anxiety, and disrupted sleep in the second half of the cycle. Many women at this stage have no idea they are in early perimenopause, because periods remain regular and the concept of menopause feels far off.
Cycle irregularity becomes noticeable. Periods may come closer together, then space out, or vary dramatically in flow. Both oestrogen and progesterone are now fluctuating more widely. Hot flushes and night sweats typically begin here. Sleep disruption becomes more significant, mood changes become less predictable, and cognitive symptoms including brain fog and poor memory begin to surface. This is the stage at which most women seek answers, often only to be told their hormones are “normal for their age.”
Periods become increasingly infrequent, with gaps of two, three, or more months. Oestrogen levels are now declining more steeply and consistently, and low-oestrogen symptoms such as vaginal dryness, joint pain, skin thinning, and cardiovascular changes become more prominent. Hot flushes and sleep disruption may intensify before eventually settling after menopause. Bone density protection, cardiovascular health, and metabolic function become increasingly important considerations at this stage.
One of the most important and least communicated facts about perimenopause is that it involves far more than hot flushes. Research has now identified over 34 recognised symptoms associated with the transition. Understanding the full range helps explain why so many women are investigated for thyroid problems, anxiety disorders, or heart conditions when the underlying driver is hormonal transition.
“What strikes me most in practice is how many women describe their perimenopause symptoms as feeling like they are going mad, because they are experiencing things they have never experienced before, that change from week to week, and that no one has named for them. Once we name perimenopause and explain the hormonal mechanism behind each symptom, the relief is immediate. Understanding what your body is doing is itself therapeutic. From there we can build a practical, evidence-based plan that actually addresses the root cause rather than patching individual symptoms in isolation.”Dr Olwethu Sotondoshe | Natural Hormone Health Practitioner & Homeopath | Ask Dr Olz
Perimenopause symptoms are not random. Each cluster has a specific hormonal mechanism, which is why treatment works best when it targets the actual driver rather than suppressing the symptom.
Driven by declining oestrogen affecting the hypothalamic thermostat. When oestrogen falls, the brain’s temperature-regulating centre becomes hypersensitive to small changes in core body temperature, triggering an exaggerated heat-dissipation response. Chronic stress worsens this by keeping the sympathetic nervous system on high alert, which lowers the flush threshold further. The Australasian Menopause Society confirms oestrogen decline as the primary driver of vasomotor symptoms across international populations, consistent with what is observed in South African clinical practice.
Progesterone has a direct calming effect on the GABA-A receptor in the brain. As progesterone falls, this natural anxiolytic effect is lost, often producing anxiety that feels neurological rather than situational, meaning it appears without an obvious trigger. Simultaneously, oestrogen fluctuations affect serotonin and dopamine availability, contributing to low mood, tearfulness, and emotional unpredictability.
Oestrogen has neuroprotective and neurotrophic effects. It supports blood flow to the brain, mitochondrial function in neurons, and the production of acetylcholine, a neurotransmitter critical for memory and focus. When oestrogen fluctuates widely, cognitive clarity often follows, producing the classic brain fog that many perimenopausal women describe as one of their most distressing symptoms.
Multiple hormonal mechanisms converge on sleep. Night sweats physically interrupt sleep. Falling progesterone removes its sedative effect on the brain. Disrupted cortisol rhythm, often from accumulated stress, produces 3am waking. And declining melatonin sensitivity with age compounds the problem further. This is why sleep in perimenopause typically needs to be addressed from several angles simultaneously rather than a single supplement or sleeping pill.
The perimenopausal metabolic shift is real and measurable. Falling oestrogen reduces insulin sensitivity, promotes fat redistribution toward the abdomen, and slows the rate at which the body burns fuel at rest. Simultaneously, rising cortisol from stress and sleep deprivation drives further abdominal fat storage. Women who have never struggled with weight management in their 30s frequently notice a significant shift in body composition during perimenopause that resists their previous approaches to diet and exercise.
Several structural and clinical factors contribute to perimenopause being missed or mislabelled in South African primary care.
Many clinicians and women themselves associate perimenopause with the years immediately before periods stop. The concept of a ten-year transition beginning in the early 40s, or even late 30s, is not widely communicated. Women in their early 40s with clear perimenopausal symptoms are often told they are too young to be perimenopausal, without further investigation.
A single FSH blood test is frequently used as a proxy for menopausal status. FSH levels fluctuate significantly during perimenopause, making a single measurement unreliable. A woman tested on a high-oestrogen day of her cycle may show a normal FSH despite being clearly perimenopausal by symptom picture. Proper assessment requires multiple markers including oestradiol, progesterone timed to the cycle, FSH, LH, full thyroid, and cortisol, alongside a thorough clinical history.
Because perimenopause produces such a wide range of symptoms, women often present to different specialists for different complaints. The cardiologist investigates palpitations. The psychologist treats anxiety. The GP investigates thyroid. None of them, working in isolation, connects the constellation back to hormonal transition. A practitioner working with a whole-body, root-cause lens is far better placed to make that connection.
Important: A normal FSH result does not rule out perimenopause. If you have a clear symptom picture and your GP has told you your hormones are fine based on a single FSH test, it is worth seeking a more comprehensive assessment.
Take the free Hormone Assessment Quiz to map your symptoms to a likely hormonal pattern, built specifically for South African women.
Take the Free Quiz NowAccurate perimenopause assessment requires more than a single blood draw. A comprehensive panel should include oestradiol and progesterone tested at the appropriate cycle day, FSH and LH, a full thyroid panel including free T3 and reverse T3, a four-point cortisol assessment, fasting insulin and glucose, and key nutrients including ferritin, vitamin D, and B12. For women with significant or complex symptoms, the DUTCH comprehensive hormone test provides a more detailed picture of hormone metabolite patterns, cortisol rhythm, and oestrogen clearance pathways. A full breakdown of hormone testing options available in South Africa is covered in our complete guide to hormone imbalance in South African women.
The most important element is not just which tests are ordered but how they are interpreted. Perimenopausal hormone levels are, by definition, in flux. A skilled integrative practitioner reads results in the context of where you are in your cycle, your full symptom picture, your stress load, and your health history, rather than simply checking whether a number falls within a reference range.
Effective perimenopause management is not about a single intervention. It is a layered, personalised strategy that addresses the specific pattern driving your symptoms, in the right sequence.
Chronic stress worsens every perimenopausal symptom. It lowers the hot flush threshold, depletes progesterone further through the pregnenolone steal, drives abdominal weight gain, disrupts sleep, and amplifies anxiety. No hormonal intervention works optimally in a chronically stressed nervous system. Adrenal support through adaptogenic herbs, targeted B vitamins and magnesium, sleep optimisation, and meaningful stress load reduction is foundational before any further hormonal work.
During perimenopause, oestrogen swings rather than falls steadily. Supporting the liver’s ability to efficiently metabolise and clear oestrogen through its phase 1 and phase 2 pathways reduces the intensity of both high-oestrogen symptoms (breast tenderness, heavy bleeding, mood volatility) and the rebound low-oestrogen effects that follow. DIM, calcium D-glucarate, sulforaphane, and B vitamins are the primary clinical tools here.
Progesterone falls earlier and more steeply than oestrogen in the perimenopause transition, and it is frequently the first deficiency producing clear symptoms. Nutritional support including zinc, B6, magnesium, and vitamin C supports endogenous progesterone production. For women with significant deficiency confirmed by testing, bioidentical progesterone, structurally identical to the body’s own progesterone, offers a clinically meaningful option with a well-established safety profile distinct from synthetic progestins.
The perimenopausal metabolic change requires a deliberate dietary shift: adequate protein at every meal to support muscle mass and satiety, reduced refined carbohydrates to manage the declining insulin sensitivity, and resistance training to counter the muscle loss that accelerates oestrogen decline. This is not about eating less. It is about eating differently in response to a changed hormonal context.
For women with moderate to severe perimenopausal symptoms, or where the symptom burden is significantly affecting quality of life, bioidentical hormone therapy guided by comprehensive testing is a clinically appropriate and evidence-supported option. Bioidentical hormones are molecularly identical to the hormones your ovaries produce. They are not the same as the synthetic hormones used in older HRT studies whose risk data is often incorrectly applied to all hormone therapy. The decision to use bioidentical hormone therapy is made individually, based on full assessment, symptom severity, personal health history, and informed preference.
“Perimenopause is not a disease to be endured. It is a hormonal transition that, when properly supported, most women can navigate with far less suffering than they have been led to expect. The women who do best are those who get a clear diagnosis early, understand what is driving each symptom, and follow a structured plan rather than trying one supplement after another hoping something sticks. The goal is not to mask perimenopause. It is to give the body what it needs to transition with resilience.”Dr Olwethu Sotondoshe | Natural Hormone Health Practitioner & Homeopath | Ask Dr Olz
Book a telehealth consultation with Dr Olwethu Sotondoshe for comprehensive perimenopause assessment and a personalised root-cause plan that actually addresses what is driving your symptoms.
Start With the Free Hormone QuizThe earliest signs are often subtle and easy to dismiss: worsening PMS, heavier periods, new or increased anxiety in the second half of the cycle, disrupted sleep around menstruation, and a lower tolerance for stress than you previously had. These signs appear because progesterone begins to decline before oestrogen does, shifting the hormonal balance and affecting mood, sleep, and cycle regularity. Many women are in early perimenopause for years before they connect these changes to hormonal transition.
Perimenopause most commonly begins in the early to mid 40s, though the transition can start as early as the late 30s. The average age of menopause in South African women is approximately 50 to 51, meaning the perimenopause transition often spans an entire decade. Genetics, chronic stress, nutritional status, and environmental factors all influence when the transition begins and how long it lasts.
Yes, and this is one of the most frequently missed connections in primary care. Falling progesterone removes its natural calming effect on the GABA-A receptor, producing anxiety that feels neurological rather than situational. Fluctuating oestrogen affects serotonin and dopamine availability, contributing to low mood, tearfulness, and emotional instability. Many women are placed on antidepressants or anxiolytics during perimenopause without ever having the hormonal driver identified or addressed.
Perimenopause lasts on average four to eight years, though the range is wide. Some women transition relatively quickly over two to three years, while others experience hormonal fluctuation for a decade or more before reaching menopause. Symptoms typically peak during the later stages of perimenopause when hormonal swings are most pronounced, and gradually settle in the years following the final period.
Perimenopause is the transitional phase leading up to menopause, during which hormones fluctuate unpredictably and periods become irregular. Menopause is a single point in time, defined retrospectively as twelve consecutive months without a period. Everything before that point is perimenopause. The distinction matters clinically because perimenopausal hormones swing erratically, requiring a different assessment and treatment approach compared to the steadier low-hormone state of established menopause.